{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:05:07Z","timestamp":1792263907610,"version":"4.4.0"},"update-to":[{"DOI":"10.1002\/14651858.cd013125","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T00:00:00Z","timestamp":1579132800000}}],"reference-count":150,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd013125.pub2","type":"journal-article","created":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T21:11:16Z","timestamp":1579900276000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Antibiotic prophylaxis to prevent spontaneous bacterial peritonitis in people with liver cirrhosis: a network meta-analysis"],"prefix":"10.1002","author":[{"given":"Oluyemi","family":"Komolafe","sequence":"first","affiliation":[{"name":"University College London; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Roberts","sequence":"additional","affiliation":[{"name":"University College London; Division of Surgery and Interventional Science; London UK NW3 2PF"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne C","family":"Freeman","sequence":"additional","affiliation":[{"name":"University of Leicester; Department of Health Sciences; University Road Leicester UK LE1 7RH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Wilson","sequence":"additional","affiliation":[{"name":"University College London Hospitals NHS Foundation Trust; Clinical Microbiology and Virology; 5th Floor Central 250 Euston Road London UK NW1 2PG"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex J","family":"Sutton","sequence":"additional","affiliation":[{"name":"University of Leicester; Department of Health Sciences; University Road Leicester UK LE1 7RH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola J","family":"Cooper","sequence":"additional","affiliation":[{"name":"University of Leicester; Department of Health Sciences; University Road Leicester UK LE1 7RH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chavdar S","family":"Pavlov","sequence":"additional","affiliation":[{"name":"'Sechenov' First Moscow State Medical University; Center for Evidence-Based Medicine; Pogodinskja st. 1\\1 Moscow Russian Federation 119881"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth Jane","family":"Milne","sequence":"additional","affiliation":[{"name":"Coventry University; Centre for Trust, Peace and Social Relations; Coventry UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Hawkins","sequence":"additional","affiliation":[{"name":"University of Glasgow; HEHTA; University Ave Glasgow G12 8QQ Glasgow UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxine","family":"Cowlin","sequence":"additional","affiliation":[{"name":"PSC Support; PO Box 6945 London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Thorburn","sequence":"additional","affiliation":[{"name":"Royal Free Hospital and the UCL Institute of Liver and Digestive Health; Sheila Sherlock Liver Centre; Pond Street London UK NW3 2QG"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian R","family":"Davidson","sequence":"additional","affiliation":[{"name":"University College London; Division of Surgery and Interventional Science; London UK NW3 2PF"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Tsochatzis","sequence":"additional","affiliation":[{"name":"Royal Free Hospital and the UCL Institute of Liver and Digestive Health; Sheila Sherlock Liver Centre; Pond Street London UK NW3 2QG"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurinchi Selvan","family":"Gurusamy","sequence":"additional","affiliation":[{"name":"University College London; Division of Surgery and Interventional Science; London UK NW3 2PF"},{"name":"'Sechenov' First Moscow State Medical University; Center for Evidence-Based Medicine; Pogodinskja st. 1\\1 Moscow Russian Federation 119881"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,1,16]]},"reference":[{"issue":"1 Suppl","key":"10.1002\/14651858.CD013125.pub2-BIB0001|cit1","first-page":"s390","article-title":"Combined norfloxacin and rifaximin as primary prophylaxis for spontaneous bacterial peritonitis","volume":"10","author":"Abdel Motelleb","year":"2016","journal-title":"Hepatology International"},{"issue":"4","key":"10.1002\/14651858.CD013125.pub2-BIB0002|cit2","first-page":"269","article-title":"Efficacy of rifaximin in prevention of recurrence of hepatic encephalopathy in patients with cirrhosis of liver","volume":"24","author":"Ali","year":"2014","journal-title":"Journal of the College of Physicians and Surgeons Pakistan"},{"issue":"4","key":"10.1002\/14651858.CD013125.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1590\/S0004-28032005000400012","article-title":"Trimethoprim-sulfamethoxazole versus norfloxacin in the prophylaxis of spontaneous bacterial peritonitis in cirrhosis","volume":"42","author":"Alvarez","year":"2005","journal-title":"Arquivos de Gastroenterologia"},{"issue":"2","key":"10.1002\/14651858.CD013125.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s12072-015-9688-z","article-title":"Efficacy and safety of alternating norfloxacin and rifaximin as primary prophylaxis for spontaneous bacterial peritonitis in cirrhotic ascites: a prospective randomized open-label comparative multicenter study","volume":"10","author":"Assem","year":"2016","journal-title":"Hepatology International"},{"key":"10.1002\/14651858.CD013125.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"s188","DOI":"10.1016\/S0168-8278(15)30004-0","article-title":"Rifaximin and propranolol combination therapy is more effective than propranolol monotherapy in the hepatic venous pressure gradient response and propranolol dose reduction-a pilot study","volume":"62","author":"Baik","year":"2015","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD013125.pub2-BIB0006|cit6","first-page":"1179a","article-title":"Rifaximin and propranolol combination therapy is more effective than propranolol monotherapy in the hepatic venous pressure gradient response and propranolol dose reduction-a pilot study","volume":"60","author":"Cho","year":"2014","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"1 Suppl 1","key":"10.1002\/14651858.CD013125.pub2-BIB0007|cit7","first-page":"1027a","article-title":"Oral rifaximin soluble solid dispersion immediate-release 40 mg prevents development of cirrhosis-related complications: a phase 2, randomized, multicenter, double-blind, placebo-controlled trial","volume":"64","author":"Bajaj","year":"2016","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"1 Suppl 1","key":"10.1002\/14651858.CD013125.pub2-BIB0008|cit8","first-page":"47a","article-title":"Impact of baseline chronic liver disease characteristics on the efficacy of oral rifaximin soluble solid dispersion tablets for the prevention of further decompensation or all-cause mortality in patients with cirrhosis and ascites","volume":"64","author":"Sanyal","year":"2016","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD013125.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"s39","DOI":"10.1016\/S0168-8278(09)60095-7","article-title":"Rifaximin is effective in maintaining remission in hepatic encephalopathy: results of a large, randomized, placebo controlled trial","volume":"50","author":"Bass","year":"2009","journal-title":"Journal of Hepatology"},{"issue":"12","key":"10.1002\/14651858.CD013125.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","article-title":"Rifaximin treatment in hepatic encephalopathy","volume":"362","author":"Bass","year":"2010","journal-title":"New England Journal of Medicine"},{"issue":"4 Suppl","key":"10.1002\/14651858.CD013125.pub2-BIB0011|cit11","first-page":"449a","article-title":"Rifaximin significantly improved critical flicker frequency, and time-weighted CFF correlated with overt hepatic encephalopathy as assessed by Conn score in a 6 month study","volume":"50","author":"Brown","year":"2009","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1002\/14651858.CD013125.pub2-BIB0012|cit12","first-page":"916a","article-title":"A critical flicker frequency value of 32 Hz predicts recurrence of overt hepatic encephalopathy in a double-blind, placebo controlled trial of rifaximin in patients with cirrhosis","volume":"56","author":"Butterworth","year":"2012","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"4 Suppl","key":"10.1002\/14651858.CD013125.pub2-BIB0013|cit13","first-page":"861a","article-title":"Impact of liver disease status and treatment with rifaximin on complications of cirrhosis in a randomized, placebo-controlled trial","volume":"58","author":"Flamm","year":"2013","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD013125.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"s84","DOI":"10.1016\/S0168-8278(09)60209-9","article-title":"Safety of rifaximin in patients with hepatic encephalopathy: results of a randomized, phase 3, placebo-controlled clinical trial","volume":"50","author":"Mullen","year":"2009","journal-title":"Journal of Hepatology"},{"issue":"5 Suppl","key":"10.1002\/14651858.CD013125.pub2-BIB0015|cit15","first-page":"a11","article-title":"Rifaximin reduces the risk of hospitalizations in patients with previous episodes of hepatic encephalopathy: results from a phase 3 placebo-controlled trial","volume":"136","author":"Neff","year":"2009","journal-title":"Gastroenterology"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD013125.pub2-BIB0016|cit16","first-page":"s451","article-title":"Efficacy and tolerability of rifaximin in hepatitis C patients with recurrent hepatic encephalopathy","volume":"144","author":"Neff","year":"2013","journal-title":"Gastroenterology"},{"issue":"Suppl1","key":"10.1002\/14651858.CD013125.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"s7","DOI":"10.1016\/S0168-8278(10)60017-7","article-title":"Rifaximin treatment improved quality of life in patients with hepatic encephalopathy: results of a large, randomized, placebo-controlled trial","volume":"52","author":"Sanyal","year":"2010","journal-title":"Journal of Hepatology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD013125.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"s90","DOI":"10.1016\/S0168-8278(09)60224-5","article-title":"Chronic administration of rifaximin for the maintenance of remission of hepatic encephalopathy: a subgroup analysis of a phase 3 trial","volume":"50","author":"Sanyal","year":"2009","journal-title":"Journal of Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD013125.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1023\/A:1015386901343","article-title":"Daily norfloxacin is more effective than weekly rufloxacin in prevention of spontaneous bacterial peritonitis recurrence","volume":"47","author":"Bauer","year":"2002","journal-title":"Digestive Diseases and Sciences"},{"issue":"2 Suppl 1","key":"10.1002\/14651858.CD013125.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"s211","DOI":"10.1016\/S0168-8278(16)00176-8","article-title":"Randomized controlled trial of rifaximin versus norfloxacin for secondary prophylaxis of spontaneous bacterial peritonitis","volume":"64","author":"Abd-Elsalam","year":"2016","journal-title":"Journal of Hepatology"},{"issue":"12","key":"10.1002\/14651858.CD013125.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1097\/MEG.0000000000000724","article-title":"Randomized-controlled trial of rifaximin versus norfloxacin for secondary prophylaxis of spontaneous bacterial peritonitis","volume":"28","author":"Elfert","year":"2016","journal-title":"European Journal of Gastroenterology and Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD013125.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1053\/j.gastro.2007.06.065","article-title":"Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis","volume":"133","author":"Fernandez","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD013125.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"s51","DOI":"10.1016\/S0168-8278(06)80115-7","article-title":"Randomized, double-blind placebo-controlled trial evaluating norfloxacin the primary prophylaxis of spontaneous bacterial peritonitis in cirrhotics with renal impairment, hyponatremia or severe liver failure","volume":"44","author":"Navasa","year":"2006","journal-title":"Journal of Hepatology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD013125.pub2-BIB0025|cit24","doi-asserted-by":"crossref","first-page":"s26","DOI":"10.1016\/0168-8278(90)91439-4","article-title":"Norfloxacin prevents spontaneous bacterial peritonitis (SBP) in cirrhosis final results of a multicenter double-blind placebo controlled study","volume":"11","author":"Gines","year":"1990","journal-title":"Journal of Hepatology"},{"issue":"4 pt 1","key":"10.1002\/14651858.CD013125.pub2-BIB0024|cit25","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/hep.1840120416","article-title":"Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: Results of a double-blind, placebo-controlled trial","volume":"12","author":"Gin\u00e9s","year":"1990","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"3","key":"10.1002\/14651858.CD013125.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0168-8278(98)80061-5","article-title":"Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind randomized trial","volume":"29","author":"Grangie","year":"1998","journal-title":"Journal of Hepatology"},{"issue":"11","key":"10.1002\/14651858.CD013125.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1097\/MEG.0000000000000967","article-title":"Long-term rifaximin therapy as a primary prevention of hepatorenal syndrome","volume":"29","author":"Ibrahim","year":"2017","journal-title":"European Journal of Gastroenterology and Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD013125.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/hep.28898","article-title":"Rifaximin has no effect on hemodynamics in decompensated cirrhosis: a randomized, double-blind, placebo-controlled trial","volume":"65","author":"Kimer","year":"2017","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"1 Suppl 1","key":"10.1002\/14651858.CD013125.pub2-BIB0029|cit29","first-page":"1041a","article-title":"Rifaximin has no effect on hemodynamics in decompensated cirrhosis - a randomized, double blind, placebo controlled trial","volume":"64","author":"Kimer","year":"2016","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1002\/14651858.CD013125.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"s858","DOI":"10.1016\/S0168-8278(15)31516-6","article-title":"Randomized trial with rifaximin in liver cirrhosis. Effects on the haemodynamic and inflammatory state","volume":"62","author":"Kimer","year":"2015","journal-title":"Journal of Hepatology"},{"issue":"1 Suppl 1","key":"10.1002\/14651858.CD013125.pub2-BIB0031|cit31","first-page":"1041a","article-title":"Rifaximin has limited effect on the inflammatory state and bacterial translocation in the patient with stable decompensated cirrhosis. Results from a randomized, placebo controlled trial","volume":"64","author":"Kimer","year":"2016","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"1","key":"10.1002\/14651858.CD013125.pub2-BIB0032|cit32","first-page":"32","article-title":"Role of oral antibiotics neomycin vs ciprofloxacin for secondary prophylaxis of porto-systemic encephalopathy in liver cirrhotic patients","volume":"10","author":"Latif","year":"2016","journal-title":"Pakistan Journal of Medical and Health Sciences"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD013125.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"s119","DOI":"10.1016\/S0168-8278(08)60301-3","article-title":"Spontaneous bacterial peritonitis (SBP) prophylaxis: a randomised controlled trial comparing trimethoprim-sulfamethoxazole and norfloxacin","volume":"48","author":"Lontos","year":"2008","journal-title":"Journal of Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD013125.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/1751-2980.12132","article-title":"A randomized controlled study of trimethoprim-sulfamethoxazole versus norfloxacin for the prevention of infection in cirrhotic patients","volume":"15","author":"Lontos","year":"2014","journal-title":"Journal of Digestive Diseases"},{"issue":"4","key":"10.1002\/14651858.CD013125.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/j.1572-0241.2001.03636.x","article-title":"Long-term treatment with cisapride and antibiotics in liver cirrhosis: effect on small intestinal motility, bacterial overgrowth, and liver function","volume":"96","author":"Madrid","year":"2001","journal-title":"American Journal of Gastroenterology"},{"issue":"10","key":"10.1002\/14651858.CD013125.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1185\/03007999709113333","article-title":"Rifaximin, a non-absorbable rifamycin, for the treatment of hepatic encephalopathy. A double-blind, randomised trial","volume":"13","author":"Miglio","year":"1997","journal-title":"Current Medical Research and Opinion"},{"issue":"Suppl","key":"10.1002\/14651858.CD013125.pub2-BIB0037|cit37","first-page":"282a","article-title":"Effects of norfloxacin therapy on survival in patients with Child-Pugh class C cirrhosis: results of a randomized, double-blind, placebo-controlled, multicenter trial","volume":"62","author":"Moreau","year":"2015","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1002\/14651858.CD013125.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"595213","DOI":"10.1155\/2014\/595213","article-title":"Role of pentoxifylline and sparfloxacin in prophylaxis of spontaneous bacterial peritonitis in cirrhotic patients","volume":"2014","author":"Mostafa","year":"2014","journal-title":"ISRN Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD013125.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"163","DOI":"10.5152\/tjg.2015.7782","article-title":"The efficacy and the immunomodulatory effect of rifaximin in prophylaxis of spontaneous bacterial peritonitis in cirrhotic Egyptian patients","volume":"26","author":"Mostafa","year":"2015","journal-title":"Turkish Journal of Gastroenterology"},{"issue":"1 Suppl 1","key":"10.1002\/14651858.CD013125.pub2-BIB0040|cit40","first-page":"s104","article-title":"Rifaximin versus placebo in reducing the risk of clinically overt hepatic encephalopathy recurrence in patients having cirrhosis of liver","volume":"9","author":"Nawaz","year":"2015","journal-title":"Hepatology International"},{"issue":"2","key":"10.1002\/14651858.CD013125.pub2-BIB0043|cit41","first-page":"S553","article-title":"Randomized control trial of rifaximin and norfloxacin in primary and secondary prophylaxis of spontaneous bacterial peritonitis (SBP) in cirrhotic patients","volume":"12","author":"Praharaj","year":"2018","journal-title":"Hepatology International"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD013125.pub2-BIB0041|cit42","doi-asserted-by":"crossref","first-page":"s71","DOI":"10.1016\/j.jceh.2017.05.133","article-title":"Randomized control trial of rifaximin and norfloxacin in primary and secondary prophylaxis of spontaneous bacterial peritonitis (SBP) in cirrhotic patients","volume":"7","author":"Praharaj","year":"2017","journal-title":"Journal of Clinical and Experimental Hepatology"},{"issue":"1 Suppl 1","key":"10.1002\/14651858.CD013125.pub2-BIB0042|cit43","first-page":"a57","article-title":"Randomized control trial of rifaximin and norfloxacin in primary and secondary prophylaxis of spontaneous bacterial peritonitis in cirrhotic patients","volume":"36","author":"Praharaj","year":"2017","journal-title":"Indian Journal of Gastroenterology"},{"issue":"4 pt 1","key":"10.1002\/14651858.CD013125.pub2-BIB0044|cit44","first-page":"1171","article-title":"Ciprofloxacin and long-term prevention of spontaneous bacterial peritonitis: results of a prospective controlled trial","volume":"22","author":"Rolachon","year":"1995","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"8","key":"10.1002\/14651858.CD013125.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"595","DOI":"10.7326\/0003-4819-122-8-199504150-00007","article-title":"Trimethoprim-sulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: a randomized trial","volume":"122","author":"Singh","year":"1995","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD013125.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1665-2681(19)30906-8","article-title":"Primary prophylaxis with ciprofloxacin in cirrhotic patients with ascites: a randomized, double blind study","volume":"13","author":"Tellez-Avila","year":"2014","journal-title":"Annals of Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD013125.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jhep.2008.01.024","article-title":"Ciprofloxacin in primary prophylaxis of spontaneous bacterial peritonitis: a randomized, placebo-controlled study","volume":"48","author":"Terg","year":"2008","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD013125.pub2-BIB0048|cit48","first-page":"534","article-title":"Efficacy of rifaximin as a prophylactic agent for the prevention of spontaneous bacterial peritonitis in alcoholic cirrhosis","volume":"31","author":"Trespi","year":"1999","journal-title":"Italian Journal of Gastroenterology and Hepatology"},{"issue":"8","key":"10.1002\/14651858.CD013125.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/s41395-018-0168-7","article-title":"Daily norfloxacin vs. weekly ciprofloxacin to prevent spontaneous bacterial peritonitis: a randomized controlled trial","volume":"113","author":"Yim","year":"2018","journal-title":"American Journal of Gastroenterology"},{"issue":"2 Suppl 1","key":"10.1002\/14651858.CD013125.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"s144","DOI":"10.1016\/S0168-8278(16)00030-1","article-title":"Comparison of daily norfloxacin versus weekly ciprofloxacin for the prevention of spontaneous bacterial peritonitis in cirrhotic patients: a randomized controlled trial","volume":"64","author":"Yim","year":"2016","journal-title":"Journal of Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD013125.pub2-BIB0051|cit51","first-page":"265","article-title":"Clinical study of a new nonfungal antibiotic: the trimethoprim-sulfamethoxazole combination in gastroenterology","volume":"46","author":"Anonymous","year":"1971","journal-title":"Revue Medico-Chirurgicale des Maladies du Foie"},{"issue":"42","key":"10.1002\/14651858.CD013125.pub2-BIB0052|cit52","first-page":"2055","article-title":"Significance of gastrointestinal antibiotics in gastrointestinal diseases: normix, the non-absorbable antibiotic","volume":"147","author":"Anonymous","year":"2006","journal-title":"Orvosi Hetilap"},{"issue":"41","key":"10.1002\/14651858.CD013125.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"6407","DOI":"10.3748\/wjg.v11.i41.6407","article-title":"Cycling of antibiotics for the prophylaxis of recurrent spontaneous bacterial peritonitis in a cirrhotic patient","volume":"11","author":"Assy","year":"2005","journal-title":"World Journal of Gastroenterology"},{"issue":"Suppl","key":"10.1002\/14651858.CD013125.pub2-BIB0054|cit54","first-page":"925a","article-title":"Long-term use of rifaximin is associated with reduced hospitalizations, prolonged remission: a placebo crossover analysis","volume":"56","author":"Bajaj","year":"2012","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"7","key":"10.1002\/14651858.CD013125.pub2-BIB0055|cit55","first-page":"733","article-title":"Increased survival following antibiotic prophylaxis in patients with cirrhosis and upper gastrointestinal hemorrhage","volume":"167","author":"Bendtsen","year":"2005","journal-title":"Ugeskrift for Laeger"},{"issue":"3","key":"10.1002\/14651858.CD013125.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000466750","article-title":"Influence of orally administered antibiotics on anti-T agglutinin of normal subjects and of cirrhotic patients","volume":"27","author":"Boccardi","year":"1974","journal-title":"Vox Sanguinis"},{"issue":"8","key":"10.1002\/14651858.CD013125.pub2-BIB0057|cit57","first-page":"1367","article-title":"Effect of treatment with paromomycin on endotoxemia in patients with alcoholic liver disease - a double-blind, placebo-controlled trial","volume":"21","author":"Bode","year":"1997","journal-title":"Alcoholism, Clinical and Experimental Research"},{"issue":"8","key":"10.1002\/14651858.CD013125.pub2-BIB0058|cit58","first-page":"659","article-title":"Antibiotic prophylaxis after gastrointestinal hemorrhage in liver cirrhosis - for which patients, with what antibiotics?","volume":"35","author":"Gerbes","year":"1997","journal-title":"Zeitschrift f\u00fcr Gastroenterologie"},{"issue":"3","key":"10.1002\/14651858.CD013125.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0168-8278(98)80072-X","article-title":"Antibiotic prophylaxis for spontaneous bacterial peritonitis: how and whom?","volume":"29","author":"Gines","year":"1998","journal-title":"Journal of Hepatology"},{"issue":"8","key":"10.1002\/14651858.CD013125.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/liv.12172","article-title":"Effects of the adjunctive probiotic vsl#3 on portal haemodynamics in patients with cirrhosis and large varices: a randomized trial","volume":"33","author":"Gupta","year":"2013","journal-title":"Liver International"},{"issue":"4","key":"10.1002\/14651858.CD013125.pub2-BIB0061|cit61","first-page":"333","article-title":"Prevention of bacterial infection using selective intestinal decontamination in patients with cirrhosis admitted to intensive care. Controlled study in 120 patients","volume":"55","author":"Henrion","year":"1992","journal-title":"Acta Gastro-enterologica Belgica"},{"issue":"3","key":"10.1002\/14651858.CD013125.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.jhep.2010.05.002","article-title":"Rifaximin in hepatic encephalopathy: more than just a non-absorbable antibiotic?","volume":"53","author":"Jalan","year":"2010","journal-title":"Journal of Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD013125.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1478-3231.2008.01850.x","article-title":"Norfloxacin treatment for clinically significant portal hypertension: results of a randomised double-blind placebo-controlled crossover trial","volume":"29","author":"Kemp","year":"2009","journal-title":"Liver International"},{"key":"10.1002\/14651858.CD013125.pub2-BIB0064|cit64","first-page":"379a","article-title":"Pentoxifylline therapy for hepatopulmonary syndrome: longer duration is superior to combination with rifaximin a RCT","volume":"60","author":"Kumar","year":"2014","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"11","key":"10.1002\/14651858.CD013125.pub2-BIB0065|cit65","first-page":"830","article-title":"Factors participating in development of bleeding varices in portal hypertension. Part I: bacterial infection and comparison of intravenous and peroral antibiotics effects - a randomised study","volume":"50","author":"Lata","year":"2004","journal-title":"Vnitrni Lekarstvi"},{"issue":"10","key":"10.1002\/14651858.CD013125.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/00042737-200510000-00015","article-title":"Variceal bleeding in portal hypertension: bacterial infection and comparison of efficacy of intravenous and per-oral application of antibiotics - a randomized trial","volume":"17","author":"Lata","year":"2005","journal-title":"European Journal of Gastroenterology and Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD013125.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/hep.510250306","article-title":"Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin","volume":"25","author":"Novella","year":"1997","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD013125.pub2-BIB0068|cit68","first-page":"s41","article-title":"Systemic antibiotic therapy (SAB) using ofloxacin is an effective prevention of bacterial infections in cirrhotic patients with variceal hemorrhage","volume":"16","author":"Pateron","year":"1992","journal-title":"Journal of Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD013125.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/hep.1840050320","article-title":"Oral, nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage","volume":"5","author":"Rimola","year":"1985","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"2","key":"10.1002\/14651858.CD013125.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/0016-5085(91)90038-M","article-title":"Antibiotic prophylaxis for prevention of spontaneous bacterial peritonitis?","volume":"101","author":"Schubert","year":"1991","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD013125.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/hep.23822","article-title":"Gut instinct: rifaximin for the prevention of hepatic encephalopathy","volume":"52","author":"Siddique","year":"2010","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"1","key":"10.1002\/14651858.CD013125.pub2-BIB0072|cit72","first-page":"74","article-title":"Efficacy of norfloxacin in the primary prophylaxis of spontaneous bacterial peritonitis on the survival and occurrence of hepatorenal syndrome","volume":"15","author":"Vibert","year":"2008","journal-title":"Hepato-Gastro"},{"issue":"11","key":"10.1002\/14651858.CD013125.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1055\/s-0041-103525","article-title":"The INCA trial (impact of nod2 genotype-guided antibiotic prevention on survival in patients with liver cirrhosis and ascites): precision medicine for patients with liver cirrhosis and ascites","volume":"53","author":"Casper","year":"2015","journal-title":"Zeitschrift f\u00fcr Gastroenterologie"},{"key":"10.1002\/14651858.CD013125.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13063-015-0594-4","article-title":"The INCA trial (impact of nod2 genotype-guided antibiotic prevention on survival in patients with liver cirrhosis and ascites): study protocol for a randomized controlled trial","volume":"16","author":"Casper","year":"2015","journal-title":"Trials"},{"key":"10.1002\/14651858.CD013125.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"s847","DOI":"10.1016\/S0168-8278(15)31494-X","article-title":"Design of the INCA trial (impact of nod2 genotype-guided antibiotic prevention on survival in patients with liver cirrhosis and ascites): prospective, double-blind, randomised clinical trial evaluating the impact of genotype-stratified care","volume":"62","author":"Casper","year":"2015","journal-title":"Journal of Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD013125.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jhep.2012.04.015","article-title":"Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR)","volume":"57","author":"Adam","year":"2012","journal-title":"Journal of Hepatology"},{"issue":"10","key":"10.1002\/14651858.CD013125.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1021\/bi5000564","article-title":"Mechanism of quinolone action and resistance","volume":"53","author":"Aldred","year":"2014","journal-title":"Biochemistry"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD013125.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1007\/s11739-010-0446-x","article-title":"Spontaneous bacterial peritonitis: from pathophysiology to prevention","volume":"5","author":"Bernardi","year":"2010","journal-title":"Internal and Emergency Medicine"},{"issue":"9","key":"10.1002\/14651858.CD013125.pub2-BIB0079|cit79","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013103","article-title":"Treatment for hepatorenal syndrome in people with decompensated liver cirrhosis: a network meta-analysis","author":"Best","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD013125.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/jrsm.57","article-title":"Using network meta-analysis to evaluate the existence of small-study effects in a network of interventions","volume":"3","author":"Chaimani","year":"2012","journal-title":"Research Synthesis Methods"},{"issue":"10","key":"10.1002\/14651858.CD013125.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"e76654","DOI":"10.1371\/journal.pone.0076654","article-title":"Graphical tools for network meta-analysis in STATA","volume":"8","author":"Chaimani","year":"2013","journal-title":"PloS One"},{"issue":"3","key":"10.1002\/14651858.CD013125.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","article-title":"SPIRIT 2013 statement: defining standard protocol items for clinical trials","volume":"158","author":"Chan","year":"2013","journal-title":"Annals of Internal Medicine"},{"issue":"9","key":"10.1002\/14651858.CD013125.pub2-BIB0083|cit83","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002907.pub2","article-title":"Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding","author":"Chavez-Tapia","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD013125.pub2-BIB0084|cit84","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004791.pub2","article-title":"Antibiotic prophylaxis for spontaneous bacterial peritonitis in cirrhotic patients with ascites, without gastro-intestinal bleeding","author":"Cohen","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD013125.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies","volume":"44","author":"D'Amico","year":"2006","journal-title":"Journal of Hepatology"},{"issue":"10","key":"10.1002\/14651858.CD013125.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/apt.12721","article-title":"Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients","volume":"39","author":"D'Amico","year":"2014","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD013125.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension: report of the Baveno VI consensus workshop: stratifying risk and individualizing care for portal hypertension","volume":"63","author":"Franchis","year":"2015","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD013125.pub2-BIB0088|cit88","doi-asserted-by":"crossref","unstructured":"Devani K Charilaou P Jaiswal P Patil N Radadiya D Patel P Trends in hospitalization, acute kidney injury, and mortality in patients with spontaneous bacterial peritonitis Journal of Clinical Gastroenterology 2019 e68 e74 10.1097\/MCG.0000000000000973","DOI":"10.1097\/MCG.0000000000000973"},{"issue":"7-8","key":"10.1002\/14651858.CD013125.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/sim.3767","article-title":"Checking consistency in mixed treatment comparison meta-analysis","volume":"29","author":"Dias","year":"2010","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD013125.pub2-BIB0090|cit90","unstructured":"Dias S Sutton AJ Welton NJ Ades AE NICE DSU technical support document 3: heterogeneity: subgroups, meta-regression, bias and bias-adjustment, September 2011 (last updated April 2012) nicedsu.org.uk\/wp-content\/uploads\/2016\/03\/TSD3-Heterogeneity.final-report.08.05.12.pdf"},{"key":"10.1002\/14651858.CD013125.pub2-BIB0091|cit91","unstructured":"Dias S Welton NJ Sutton AJ Ades AE NICE DSU technical support document 1: introduction to evidence synthesis for decision making, April 2011 (last updated April 2012) scharr.dept.shef.ac.uk\/nicedsu\/wp-content\/uploads\/sites\/7\/2016\/03\/TSD1-Introduction.final_.08.05.12.pdf"},{"key":"10.1002\/14651858.CD013125.pub2-BIB0092|cit92","unstructured":"Dias S Welton NJ Sutton AJ Caldwell DM Lu G Ades AE NICE DSU technical support document 4: inconsistency in networks of evidence based on randomised controlled trials, May 2011 (last updated April 2014) nicedsu.org.uk\/wp-content\/uploads\/2016\/03\/TSD4-Inconsistency.final_.15April2014.pdf"},{"key":"10.1002\/14651858.CD013125.pub2-BIB0093|cit93","unstructured":"Dias S Welton NJ Sutton AJ Ades AE NICE DSU technical support document 2: a generalised linear modelling framework for pairwise and network meta-analysis of randomised controlled trials, August 2011 (last updated September 2016) www.ncbi.nlm.nih.gov\/pubmedhealth\/PMH0088912\/pdf\/PubMedHealth_PMH0088912.pdf"},{"issue":"8","key":"10.1002\/14651858.CD013125.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.mayocp.2015.04.016","article-title":"Therapeutic effects and mechanisms of action of rifaximin in gastrointestinal diseases","volume":"90","author":"DuPont","year":"2015","journal-title":"Mayo Clinic Proceedings"},{"issue":"3","key":"10.1002\/14651858.CD013125.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2010.05.004","article-title":"EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis","volume":"53","author":"European Association for the Study of the Liver","year":"2010","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD013125.pub2-BIB0096|cit96","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis Journal of Hepatology 2018 406 60 10.1016\/j.jhep.2018.03.024","DOI":"10.1016\/j.jhep.2018.03.024"},{"key":"10.1002\/14651858.CD013125.pub2-BIB0097|cit97","unstructured":"EuroQol EQ-5D Instruments | About EQ-5D, 2018 euroqol.org\/eq-5d-instruments\/"},{"issue":"5","key":"10.1002\/14651858.CD013125.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.jhep.2008.05.023","article-title":"Incidence and prevalence of cirrhosis in the united kingdom, 1992-2001: a general population-based study","volume":"49","author":"Fleming","year":"2008","journal-title":"Journal of Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD013125.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/j.1875-9114.1981.tb03548.x","article-title":"Trimethoprim: mechanisms of action, antimicrobial activity, bacterial resistance, pharmacokinetics, adverse reactions, and therapeutic indications","volume":"1","author":"Gleckman","year":"1981","journal-title":"Pharmacotherapy"},{"issue":"11-12","key":"10.1002\/14651858.CD013125.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/apt.14361","article-title":"Systematic review with meta-analysis: rifaximin for the prophylaxis of spontaneous bacterial peritonitis","volume":"46","author":"Goel","year":"2017","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD013125.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"e025045","DOI":"10.1136\/bmjopen-2018-025045","article-title":"Top research priorities in liver and gallbladder disorders in the UK","volume":"9","author":"Gurusamy","year":"2019","journal-title":"BMJ Open"},{"issue":"4","key":"10.1002\/14651858.CD013125.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD013125.pub2-BIB0103|cit103","unstructured":"Higgins JP Green S editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"2","key":"10.1002\/14651858.CD013125.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/jrsm.1044","article-title":"Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies","volume":"3","author":"Higgins","year":"2012","journal-title":"Research Synthesis Methods"},{"issue":"11","key":"10.1002\/14651858.CD013125.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD013125.pub2-BIB0106|cit106","volume-title":"International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice CFR & ICH Guidelines","volume":"1","author":"International Conference on Harmonisation Expert Working Group","year":"1997"},{"issue":"21","key":"10.1002\/14651858.CD013125.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1002\/sim.6188","article-title":"A design-by-treatment interaction model for network meta-analysis with random inconsistency effects","volume":"33","author":"Jackson","year":"2014","journal-title":"Statistics in Medicine"},{"issue":"10","key":"10.1002\/14651858.CD013125.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/MEG.0000000000000940","article-title":"Rifaximin for the prevention of spontaneous bacterial peritonitis and hepatorenal syndrome in cirrhosis: a systematic review and meta-analysis","volume":"29","author":"Kamal","year":"2017","journal-title":"European Journal of Gastroenterology & Hepatology"},{"issue":"8","key":"10.1002\/14651858.CD013125.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1080\/00365520902964739","article-title":"Ascites: aetiology, mortality and the prevalence of spontaneous bacterial peritonitis","volume":"44","author":"Khan","year":"2009","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"11","key":"10.1002\/14651858.CD013125.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses","volume":"135","author":"Kjaergard","year":"2001","journal-title":"Annals of Internal Medicine"},{"issue":"474","key":"10.1002\/14651858.CD013125.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1198\/016214505000001302","article-title":"Assessing evidence inconsistency in mixed treatment comparisons","volume":"101","author":"Lu","year":"2006","journal-title":"Journal of the American Statistical Association"},{"key":"10.1002\/14651858.CD013125.pub2-BIB0112|cit112","first-page":"i124","article-title":"Decompensated alcohol related liver disease: acute management","volume":"352","author":"McPherson","year":"2016","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"4","key":"10.1002\/14651858.CD013125.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1055\/s-0030-1267541","article-title":"Current status and future of liver transplantation","volume":"30","author":"Merion","year":"2010","journal-title":"Seminars in Liver Disease"},{"issue":"12","key":"10.1002\/14651858.CD013125.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1001\/2012.jama.11228","article-title":"How to use an article reporting a multiple treatment comparison meta-analysis","volume":"308","author":"Mills","year":"2012","journal-title":"JAMA"},{"issue":"9128","key":"10.1002\/14651858.CD013125.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD013125.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12916-014-0145-y","article-title":"Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis","volume":"12","author":"Mokdad","year":"2014","journal-title":"BMC Medicine"},{"key":"10.1002\/14651858.CD013125.pub2-BIB0117|cit117","unstructured":"National Center for Biotechnology Information Liver cirrhosis www.ncbi.nlm.nih.gov\/mesh\/68008103"},{"key":"10.1002\/14651858.CD013125.pub2-BIB0118|cit118","unstructured":"National Center for Biotechnology Information Ascites www.ncbi.nlm.nih.gov\/mesh\/68001201"},{"issue":"5","key":"10.1002\/14651858.CD013125.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/ije\/21.5.837","article-title":"Intention-to-treat analysis: implications for quantitative and qualitative research","volume":"21","author":"Newell","year":"1992","journal-title":"International Journal of Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD013125.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/hep.21588","article-title":"Diagnostic accuracy of the multistix 8 sg reagent strip in diagnosis of spontaneous bacterial peritonitis","volume":"45","author":"Nousbaum","year":"2007","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1002\/14651858.CD013125.pub2-BIB0121|cit121","unstructured":"Optum Patient-reported outcomes | What we do | SF Health Surveys | SF-36v2 Health Survey, 2018 campaign.optum.com\/optum-outcomes\/what-we-do\/health-surveys\/sf-36v2-health-survey.html"},{"key":"10.1002\/14651858.CD013125.pub2-BIB0122|cit122","first-page":"g5630","article-title":"A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis","volume":"349","author":"Puhan","year":"2014","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"8","key":"10.1002\/14651858.CD013125.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/ajg.2015.191","article-title":"Causes of death in people with liver cirrhosis in England compared with the general population: a population-based cohort study","volume":"110","author":"Ratib","year":"2015","journal-title":"American Journal of Gastroenterology"},{"issue":"9","key":"10.1002\/14651858.CD013125.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1093\/bja\/44.9.910","article-title":"Clinical physiology of the liver","volume":"44","author":"Read","year":"1972","journal-title":"British Journal of Anaesthesia"},{"issue":"1","key":"10.1002\/14651858.CD013125.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0168-8278(00)80201-9","article-title":"Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club","volume":"32","author":"Rimola","year":"2000","journal-title":"Journal of Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD013125.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1017\/S0266462303000552","article-title":"Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches","volume":"19","author":"Royle","year":"2003","journal-title":"International Journal of Technology Assessment in Health Care"},{"issue":"4","key":"10.1002\/14651858.CD013125.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/hep.26359","article-title":"Management of adult patients with ascites due to cirrhosis: an update","volume":"57","author":"Runyon","year":"2013","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"4","key":"10.1002\/14651858.CD013125.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/ajg.2009.3","article-title":"Oral antibiotic prophylaxis reduces spontaneous bacterial peritonitis occurrence and improves short-term survival in cirrhosis: a meta-analysis","volume":"104","author":"Saab","year":"2009","journal-title":"American Journal of Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD013125.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial","volume":"64","author":"Salanti","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD013125.pub2-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/jrsm.1037","article-title":"Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool","volume":"3","author":"Salanti","year":"2012","journal-title":"Research Synthesis Methods"},{"issue":"35","key":"10.1002\/14651858.CD013125.pub2-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta16350","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomized controlled trials: combined analysis of meta-epidemiological studies","volume":"16","author":"Savovi\u0107","year":"2012","journal-title":"Health Technology Assessment"},{"issue":"6","key":"10.1002\/14651858.CD013125.pub2-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-157-6-201209180-00537","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomized controlled trials","volume":"157","author":"Savovi\u0107","year":"2012","journal-title":"Annals of Internal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD013125.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/aje\/kwx344","article-title":"Association between risk-of-bias assessments and results of randomized trials in Cochrane Reviews: the ROBES Meta-Epidemiologic Study","volume":"187","author":"Savovi\u0107","year":"2018","journal-title":"American Journal of Epidemiology"},{"issue":"8","key":"10.1002\/14651858.CD013125.pub2-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/MCG.0000000000000208","article-title":"The epidemiology of cirrhosis in the united states: a population-based study","volume":"49","author":"Scaglione","year":"2015","journal-title":"Journal of Clinical Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD013125.pub2-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD013125.pub2-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"c332","DOI":"10.1136\/bmj.c332","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Schulz","year":"2010","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"6","key":"10.1002\/14651858.CD013125.pub2-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1002\/hep.28677","article-title":"Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups: the multiethnic cohort","volume":"64","author":"Setiawan","year":"2016","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"2","key":"10.1002\/14651858.CD013125.pub2-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.2517-6161.1993.tb01921.x","article-title":"Bayesian interval estimates which are also confidence intervals","volume":"55","author":"Severini","year":"1993","journal-title":"Journal of the Royal Statistical Society. Series B, Statistical Methodology"},{"issue":"1","key":"10.1002\/14651858.CD013125.pub2-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"e000154","DOI":"10.1136\/bmjgast-2017-000154","article-title":"Rifaximin versus norfloxacin for prevention of spontaneous bacterial peritonitis: a systematic review","volume":"4","author":"Sidhu","year":"2017","journal-title":"BMJ Open Gastroenterology"},{"key":"10.1002\/14651858.CD013125.pub2-BIB0140|cit140","unstructured":"StataCorp LLC Stata 2017"},{"issue":"3","key":"10.1002\/14651858.CD013125.pub2-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.cgh.2010.11.038","article-title":"Renal dysfunction is the most important independent predictor of mortality in cirrhotic patients with spontaneous bacterial peritonitis","volume":"9","author":"Tandon","year":"2011","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"9930","key":"10.1002\/14651858.CD013125.pub2-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/S0140-6736(14)60121-5","article-title":"Liver cirrhosis","volume":"383","author":"Tsochatzis","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD013125.pub2-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jhep.2017.01.011","article-title":"Diagnosis and treatment of ascites","volume":"67","author":"Tsochatzis","year":"2017","journal-title":"Journal of Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD013125.pub2-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/ije\/dys041","article-title":"Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews","volume":"41","author":"Turner","year":"2012","journal-title":"International Journal of Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD013125.pub2-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/jrsm.1054","article-title":"Automating network meta-analysis","volume":"3","author":"Valkenhoef","year":"2012","journal-title":"Research Synthesis Methods"},{"issue":"9958","key":"10.1002\/14651858.CD013125.pub2-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/S0140-6736(14)61838-9","article-title":"Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis","volume":"384","author":"Williams","year":"2014","journal-title":"Lancet"},{"issue":"7644","key":"10.1002\/14651858.CD013125.pub2-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study","volume":"336","author":"Wood","year":"2008","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD013125.pub2-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jclinepi.2019.04.018","article-title":"Development of the summary of findings table for network meta-analysis","volume":"115","author":"Yepes-Nunez","year":"2019","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD013125.pub2-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1128\/AAC.32.12.1848","article-title":"Mechanism of action of cephalosporins and resistance caused by decreased affinity for penicillin-binding proteins in Bacteroides fragilis","volume":"32","author":"Yotsuji","year":"1988","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"9","key":"10.1002\/14651858.CD013125.pub2-BIB0150|cit150","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013125","article-title":"Antibiotic prophylaxis to prevent spontaneous bacterial peritonitis in people with liver cirrhosis: a network meta-analysis","author":"Gurusamy","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD013125.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T18:03:59Z","timestamp":1722362639000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD013125.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Hepato-Biliary Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,1,16]]},"references-count":150,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd013125.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,16]]}}}